![]() |
|
|
The Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA
2To whom correspondence should be addressed. E-mail: Katherine.tucker{at}tufts.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: C-reactive protein homocysteine fruit vegetable elderly
Elevated C-reactive protein (CRP)3 (13) and plasma total homocysteine (Hcy) (46) were recently identified as risk factors for cardiovascular disease (CVD). CRP is an acute phase reactant secreted by the liver in response to inflammatory cytokines. It was recently identified as a stronger predictor of cardiovascular events than LDL cholesterol (7). Recently, a meta-analysis showed that individuals in the top third of CRP plasma concentrations (>2.4 mg/L) were 2 times as likely to have coronary heart disease (CHD) relative to those in the lowest third of CRP concentrations (<1.0 mg/L) (8). Homocysteine is a sulfur-containing amino acid that is not used for the synthesis of protein. Two recent meta-analyses based on prospective studies demonstrated that every 5 µmol/L increase in Hcy increased the risk for coronary heart disease (CHD) by 20% (9,10).
Increasing fruit and vegetable consumption was shown to protect against CVD (1114). Results from the Framingham Heart Study showed that the age-adjusted risk ratio for stoke was 0.78 for every additional 3 servings/d of fruits and vegetables (15). In the Nurses Health Study and the Health Professionals Follow-Up Study, a protective effect of fruit and vegetables against risk for CHD was also observed (16). One postulated mechanism through which fruit and vegetables protect against CVD is by reduction of plasma Hcy (16). However, few studies have related fruit and vegetable consumption to inflammatory status, and neither inflammation nor Hcy has been studied extensively in Hispanic populations. Therefore, we examined the association of fruit and vegetable intake with plasma CRP and Hcy concentrations in a group of Hispanic elders living in Massachusetts, as well as with a neighborhood-matched group of non-Hispanic white elders.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
60 y, n = 779) living in Massachusetts, and a neighborhood control group of non-Hispanic whites (n = 251). We selected 339 Puerto Ricans, 106 Dominicans, and 154 non-Hispanic whites with dietary intake data and fasting plasma CRP and Hcy measurements. Hispanics of other origin were not included due to small numbers in diverse groups. The Institutional Review Board of Tufts University/New England Medical Center approved the protocol, and subjects gave informed consent before participating. Field data collection. Dietary intakes were assessed with a semiquantitative FFQ adapted and validated for use with this population (19). Reported intake frequency of individual fruit and vegetable items was summed to obtain the mean frequency of fruit and vegetables consumed per day for each person. Fruits included apples, pears, bananas, peaches, cantaloupe, watermelon, strawberries, mangoes, oranges, grapefruit, other fruit, organ or grapefruit juice, and other 100% juice. Vegetables included tomatoes, string beans, peas, broccoli, cauliflower, spinach, mustard greens, cole slaw, carrots, green salad, avocado, winter squash, other vegetables, dried beans, beans with rice, chili with beans, peas with rice, vegetable soups, and homemade soups. Median portion sizes of fruit and vegetable items of this population were described elsewhere (19). Outliers (n = 52) for energy intake were excluded when values were <2.51 MJ/d (600 kcal/d) or >16.72 MJ/d (4000 kcal/d). Vitamin supplement use (type, frequency, and dosage) was determined in the home by observing supplement packaging. Supplement information was then entered into the Minnesota Nutrient Data System (NDS) and added into the dietary intake data.
Body weight was measured with a Seca balance scale (Seca) with a capacity of 150 kg. Height was taken with a Harpenden pocket stadiometer (Holtain). BMI was calculated as weight (kg)/height (m)2.
Duplicate blood pressure measurements were taken by trained field workers. Hypertension was defined as systolic blood pressure
140 mm Hg and/or diastolic blood pressure
90 mm Hg. Subjects were identified as having type 2 diabetes when fasting plasma glucose was >7.0 mmol/L, a random plasma glucose was >11.1 mmol/L, or they reported use of medications for diabetes (insulin or oral medicines). Information on age (y), household income ($/y), education (y), smoking (current, former, and never), and current alcohol use was calculated from the FFQ. Alcohol intake was categorized as moderate (up to 1 drink/d for women and up to 2 drink/d for men) and heavy (greater then these intakes), based on 13.2 g of alcohol/drink. Use of medication was assessed in the home by obtaining medication packaging. Because medication use has been shown to affect plasma CRP and Hcy concentrations (2023), we also included the following information in this analysis (yes or no): use of aspirin, nonsteroidal anti-inflammatory drugs, antihypertensives, diuretics or cardiovascular medications, or hormones.
Blood samples were drawn from fasting subjects (12 h), collected in tubes containing 0.15% EDTA, and centrifuged at 2500 x g for 20 min at 4°C to separate plasma. CRP was measured with an Immunoturbidimetric assay (SPQ antibody reagent set II, Diasorin) (24). Among the subjects, 71% had CRP values below the lowest measurement limit of 6 mg/L, and these were presented as 3 mg/L (midway between 0 and 6). Homocysteine was measured by HPLC with fluorometric detection (25). A cut-off point of >10 mg/L was used to define high CRP concentration. CRP concentration > 10 mg/L is considered clinically elevated, suggesting systemic inflammatory processes (2628). We used this cut-off because 75.2% of the subjects in our study had one or more of the following cardiovascular conditions: hypertension, and a history of stoke, heart attack, or other heart disease. Two studies showed that CRP > 10 mg/L could predict long-term outcomes after coronary events (29,30). One of these demonstrated that a cut-off point of 10 mg/L had a positive predictive value of 44%, relative to 24% for a cut-off point of 3 mg/L. The negative predictive values of these cut-off points were 92 and 96%, respectively (30). High Hcy was defined as >10.4 µmol/L for women and >11.4 µmol/L for men, based on the 95th percentile for young adults in the third National Health and Nutrition Examination Survey (31).
Statistical analyses.
Statistical analyses were completed with SAS version 8.1 (SAS Institute). Logarithmic transformations were performed for plasma CRP and Hcy concentrations to normalize the distribution of data. We created an overall variable for frequency of total fruit and vegetable intake by summing the intake of all fruit and vegetables reported on the FFQ. Subjects were divided into quartile categories of frequency of total fruit and vegetable consumption. Means were compared using the General Linear Model procedure in SAS, with Dunnett adjustment for multiple comparisons (the lowest quartile as reference). Logistic regression was used to test differences in prevalence across quartiles and to calculate odds ratios (ORs) and 95% CIs. Analyses were adjusted for age (y), sex, ethnicity (Hispanic vs. non-Hispanic white), BMI (kg/m2), diabetes status (yes or no), hypertension status (yes or no), smoking (current, former, and never), and current alcohol use (heavy drinker, moderate drinker, and nondrinker), vitamin supplement use (yes or no), total energy intake (MJ/d), meat intake (times/d), cereal intake (times/d), dairy product intake (times/d), aspirin use, nonsteroidal anti-inflammatory drug use, antihypertensive use, diuretic or cardiovascular medication use, and hormone use. Linear trends were tested for significance by assigning each subject the median frequency of total fruit and vegetable intake (times/d) for the quartile and treating this value as a continuous variable. Interactions between fruit and vegetable intake and ethnicity were tested in all analyses. An
of 0.05 was used in all of our analyses.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Average CRP concentrations were higher in our study population than was seen in other studies. The Womens Health Study reported values of 1.5 and 6.6 mg/L as 50th and 90th percentiles (7). Similar ranges were shown elsewhere (36). In this mostly Hispanic population, >70% of subjects had hypertension and >30% were obese and diabetic (17,18). These chronic conditions are related to high plasma CRP concentration (22). Because we measured CRP using an immunoturbidimetric assay, we could not quantify CRP values < 6 mg/L. This limits our ability to extend the association of fruit and vegetable intake with CRP concentration at the lower end of the CRP distribution. However, despite this limitation, we saw a clear dose-response relation between fruit and vegetable intake and CRP concentration. This finding suggests that fruit and vegetable intake may modulate the inflammatory response. We expect that stronger associations may be observed in future studies using high-sensitivity CRP measurement.
The antioxidant components of fruit and vegetables, i.e., carotenoids, vitamin E, vitamin C, and flavonoids, may contribute to this anti-inflammatory effect. Several studies, in both humans and rats, showed an inverse relation between inflammation and dietary antioxidant intake. Consumption of a diet low in antioxidants was shown to result in inflammation (37), whereas antioxidant supplementation decreases inflammation (38). Flavonoids were shown to inhibit the synthesis and gene expression of cytokines (39). Nuclear factor (NF)-
B, an oxidant-sensitive upstream regulator of proinflammatory mediator synthesis, plays a key role in this process (38). Oxidative stress leads to NF-
B activation and DNA binding (40,41). As a result, the inflammatory cascade is triggered and CRP is subsequently produced (42). Antioxidants were shown to block NF-
B activation and DNA binding (41,4345). A recent intervention study showed that after drinking 500 mL/d of high-pressurized orange juice for 14 d, plasma CRP was reduced by 40% (from 0.25 to 0.15 mg/L) and 56% (from 0.23 to 0.10 mg/L) in men and women, respectively (46). In that study, decreases in plasma prostaglandin E2 were also observed in both men and women (46).
Our observation of an inverse association between fruit and vegetable intake and plasma Hcy concentration is consistent with results from the Framingham Heart Study in which a clear dose-response relation was identified for plasma Hcy with greater frequency of fruit and vegetable consumption (47). Several trials have shown that a high intake of fruit and vegetables reduces plasma Hcy (4851). This may be explained by the folate and vitamin B-6 content of fruit and vegetables (5254). Folate is required in the remethylation of Hcy to methionine, and vitamin B-6 is involved in the transsulfuration of Hcy to cystathionine (55). The relations of dietary folate and vitamin B-6 intake and plasma Hcy have been well established (31,52,56).
Kuller et al. (57) proposed that inflammatory processes may result in an increased demand for folate, thereby leading to secondary elevation of Hcy. Friso et al. (58) found that vitamin B-6 was associated with an elevation of CRP. These observations suggest that CRP and Hcy may share common pathways. However, we found that the significant associations of fruit and vegetable intake with plasma CRP and Hcy were independent of each other. Furthermore, we found no relation between CRP and Hcy after adjustment for age, sex, ethnicity, BMI, smoking, and alcohol use (data not shown), which is consistent with other studies (5961).
In summary, greater frequency of fruit and vegetable intake was associated with lower plasma CRP and Hcy concentrations. Because both of these metabolites are known risk factors for CVD, these findings contribute to the evidence that higher intake of fruit and vegetables may reduce the risk of CVD.
| FOOTNOTES |
|---|
3 Abbreviations used: CHD, coronary heart disease; CRP, C-reactive protein; CVD, cardiovascular disease; Hcy, homocysteine; NF, nuclear factor; OR, odds ratio. ![]()
Manuscript received 4 November 2003. Initial review completed 14 December 2003. Revision accepted 11 January 2004.
| LITERATURE CITED |
|---|
|
|
|---|
1. Ridker, P. M., Buring, J. E., Cook, N. R. & Rifai, N. (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107:391-397.
2. Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P. & Hennekens, C. H. (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336:973-979.
3. Yeh, E. T. & Willerson, J. T. (2003) Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation 107:370-371.
4. Suliman, M. E., Stenvinkel, P., Barany, P., Heimburger, O., Anderstam, B. & Lindholm, B. (2003) Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. Am. J. Kidney Dis. 41:S89-S95.[Medline]
5. Refsum, H., Ueland, P. M., Nygard, O. & Vollset, S. E. (1998) Homocysteine and cardiovascular disease. Annu. Rev. Med. 49:1-62.[Medline]
6. Wald, N. J., Watt, H. C., Law, M. R., Weir, D. G., McPartlin, J. & Scott, J. M. (1998) Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch. Intern. Med. 158:862-867.
7. Ridker, P. M., Rifai, N., Rose, L., Buring, J. E. & Cook, N. R. (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347:1557-1565.
8. Danesh, J., Whincup, P., Walker, M., Lennon, L., Thomson, A., Appleby, P., Gallimore, J. R. & Pepys, M. B. (2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. Br. Med. J. 321:199-204.
9. Ueland, P. M., Refsum, H., Beresford, S. A. & Vollset, S. E. (2000) The controversy over homocysteine and cardiovascular risk. Am. J. Clin. Nutr. 72:324-332.
10. Ford, E. S., Smith, S. J., Stroup, D. F., Steinberg, K. K., Mueller, P. W. & Thacker, S. B. (2002) Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int. J. Epidemiol. 31:59-70.
11. Rissanen, T. H., Voutilainen, S., Virtanen, J. K., Venho, B., Vanharanta, M., Mursu, J. & Salonen, J. T. (2003) Low intake of fruits, berries and vegetables is associated with excess mortality in men: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. J. Nutr. 133:199-204.
12. Liu, S., Manson, J. E., Lee, I. M., Cole, S. R., Hennekens, C. H., Willett, W. C. & Buring, J. E. (2000) Fruit and vegetable intake and risk of cardiovascular disease: the Womens Health Study. Am. J. Clin. Nutr. 72:922-928.
13. Joshipura, K. J., Ascherio, A., Manson, J. E., Stampfer, M. J., Rimm, E. B., Speizer, F. E., Hennekens, C. H., Spiegelman, D. & Willett, W. C. (1999) Fruit and vegetable intake in relation to risk of ischemic stroke. J. Am. Med. Assoc. 282:1233-1239.
14. Bazzano, L. A., He, J., Ogden, L. G., Loria, C. M., Vupputuri, S., Myers, L. & Whelton, P. K. (2002) Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am. J. Clin. Nutr. 76:93-99.
15. Gillman, M. W., Cupples, L. A., Gagnon, D., Posner, B. M., Ellison, R. C., Castelli, W. P. & Wolf, P. A. (1995) Protective effect of fruits and vegetables on development of stroke in men. J. Am. Med. Assoc. 273:1113-1117.[Abstract]
16. Joshipura, K. J., Hu, F. B., Manson, J. E., Stampfer, M. J., Rimm, E. B., Speizer, F. E., Colditz, G., Ascherio, A., Rosner, B., Spiegelman, D. & Willett, W. C. (2001) The effect of fruit and vegetable intake on risk for coronary heart disease. Ann. Intern. Med. 134:1106-1114.
17. Tucker, K. L., Falcon, L. M., Bianchi, L. A., Cacho, E. & Bermudez, O. I. (2000) Self-reported prevalence and health correlates of functional limitation among Massachusetts elderly Puerto Ricans, Dominicans, and non-Hispanic white neighborhood comparison group. J. Gerontol. A. Biol. Sci. Med. Sci. 55:M90-M97.[Abstract]
18. Tucker, K. L., Bermudez, O. I. & Castaneda, C. (2000) Type 2 diabetes is prevalent and poorly controlled among Hispanic elders of Caribbean origin. Am. J. Public Health 90:1288-1293.
19. Tucker, K. L., Bianchi, L. A., Maras, J. & Bermudez, O. I. (1998) Adaptation of a food frequency questionnaire to assess diets of Puerto Rican and non-Hispanic adults. Am. J. Epidemiol. 148:507-518.
20. Schneede, J., Refsum, H. & Ueland, P. M. (2000) Biological and environmental determinants of plasma homocysteine. Semin. Thromb. Hemost. 26:263-279.[Medline]
21. Nakagomi, A., Freedman, S. B. & Geczy, C. L. (2000) Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment. Circulation 101:1785-1791.
22. de Ferranti, S. & Rifai, N. (2002) C-reactive protein and cardiovascular disease: a review of risk prediction and interventions. Clin. Chim. Acta 317:1-15.[Medline]
23. Jenkins, N. P., Keevil, B. G., Hutchinson, I. V. & Brooks, N. H. (2002) Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease. Am. J. Med. 112:269-274.[Medline]
24. Blom, M. & Hjorne, N. (1976) Profile analysis of blood proteins with a centrifugal analyzer. Clin. Chem. 22:657-662.
25. Araki, A. & Sako, Y. (1987) Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 422:43-52.[Medline]
26. Kereiakes, D. J. (2003) The fire that burns within: C-reactive protein. Circulation 107:373-374.
27. Ridker, P. M. (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107:363-369.
28. Erlinger, T. P., Guallar, E., Miller, E. R., 3rd., Stolzenberg-Solomon, R. & Appel, L. J. (2001) Relationship between systemic markers of inflammation and serum beta-carotene levels. Arch Intern. Med. 161:1903-1908.
29. Lindahl, B., Toss, H., Siegbahn, A., Venge, P. & Wallentin, L. (2000) Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease.FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N. Engl. J. Med. 343:1139-1147.
30. Rebuzzi, A. G., Quaranta, G., Liuzzo, G., Caligiuri, G., Lanza, G. A., Gallimore, J. R., Grillo, R. L., Cianflone, D., Biasucci, L. M. & Maseri, A. (1998) Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris. Am. J. Cardiol. 82:715-719.[Medline]
31. Selhub, J., Jacques, P. F., Rosenberg, I. H., Rogers, G., Bowman, B. A., Gunter, E. W., Wright, J. D. & Johnson, C. L. (1999) Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (19911994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann. Intern. Med. 131:331-339.
32. Yeh, E. T., Anderson, H. V., Pasceri, V. & Willerson, J. T. (2001) C-reactive protein: linking inflammation to cardiovascular complications. Circulation 104:974-975.
33. Du Clos, T. W. (2000) Function of C-reactive protein. Ann. Med. 32:274-278.[Medline]
34. Rosenson, R. S. & Koenig, W. (2002) High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease. Curr. Opin. Cardiol. 17:325-331.[Medline]
35. De Bree, A., Verschuren, W. M., Kromhout, D., Kluijtmans, L. A. & Blom, H. J. (2002) Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol. Rev. 54:599-618.
36. Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S. & Gotto, A. M., Jr. (2001) Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N. Engl. J. Med. 344:1959-1965.
37. Calfee-Mason, K. G., Spear, B. T. & Glauert, H. P. (2002) Vitamin E inhibits hepatic NF-
B activation in rats administered the hepatic tumor promoter, phenobarbital. J. Nutr. 132:3178-3185.
38. Meydani, S. N., Wu, D., Santos, M. S. & Hayek, M. G. (1995) Antioxidants and immune response in aged persons: overview of present evidence. Am. J. Clin. Nutr. 62:1462S-1476S.
39. Middleton, E., Jr., Kandaswami, C. & Theoharides, T. C. (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52:673-751.
40. Lee, J. I. & Burckart, G. J. (1998) Nuclear factor kappa B: important transcription factor and therapeutic target. J. Clin. Pharmacol. 38:981-993.
41. Palozza, P., Serini, S., Torsello, A., Di Nicuolo, F., Piccioni, E., Ubaldi, V., Pioli, C., Wolf, F. I. & Calviello, G. (2003) ß-Carotene regulates NF-
B DNA-binding activity by a redox mechanism in human leukemia and colon adenocarcinoma cells. J. Nutr. 133:381-388.
42. Wanner, C. & Metzger, T. (2002) C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients. Nephrol. Dial. Transplant 17(suppl. 8):29-32 discussion 3940.
43. Islam, K. N., Devaraj, S. & Jialal, I. (1998)
-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation 98:2255-2261.
44. Li, D., Saldeen, T. & Mehta, J. L. (1999)
-Tocopherol decreases ox-LDL-mediated activation of nuclear factor-kappaB and apoptosis in human coronary artery endothelial cells. Biochem. Biophys. Res. Commun. 259:157-161.[Medline]
45. Omoya, T., Shimizu, I., Zhou, Y., Okamura, Y., Inoue, H., Lu, G., Itonaga, M., Honda, H., Nomura, M. & Ito, S. (2001) Effects of idoxifene and estradiol on NF-
B activation in cultured rat hepatocytes undergoing oxidative stress. Liver 21:183-191.[Medline]
46. Sanchez-Moreno, C., Cano, M. P., de Ancos, B., Plaza, L., Olmedilla, B., Granado, F. & Martin, A. (2003) High-pressurized orange juice consumption affects plasma vitamin C, antioxidative status and inflammatory markers in healthy humans. J. Nutr. 133:2204-2209.
47. Tucker, K. L., Selhub, J., Wilson, P. W. & Rosenberg, I. H. (1996) Dietary intake pattern relates to plasma folate and homocysteine concentrations in the Framingham Heart Study. J. Nutr. 126:3025-3031.
48. Appel, L. J., Miller, E. R., 3rd., Jee, S. H., Stolzenberg-Solomon, R., Lin, P. H., Erlinger, T., Nadeau, M. R. & Selhub, J. (2000) Effect of dietary patterns on serum homocysteine: results of a randomized, controlled feeding study. Circulation 102:852-857.
49. Rock, C. L., Moskowitz, A., Huizar, B., Saenz, C. C., Clark, J. T., Daly, T. L., Chin, H., Behling, C. & Ruffin, M. T. (2001) High vegetable and fruit diet intervention in premenopausal women with cervical intraepithelial neoplasia. J. Am. Diet Assoc. 101:1167-1174.[Medline]
50. Broekmans, W. M., Klopping-Ketelaars, I. A., Schuurman, C. R., Verhagen, H., van den Berg, H., Kok, F. J. & van Poppel, G. (2000) Fruits and vegetables increase plasma carotenoids and vitamins and decrease homocysteine in humans. J. Nutr. 130:1578-1583.
51. Brouwer, I. A., van Dusseldorp, M., West, C. E., Meyboom, S., Thomas, C. M., Duran, M., van het Hof, K. H., Eskes, T. K., Hautvast, J. G. & Steegers-Theunissen, R. P. (1999) Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J. Nutr. 129:1135-1139.
52. Tucker, K. L., Mahnken, B., Wilson, P. W., Jacques, P. & Selhub, J. (1996) Folic acid fortification of the food supply.Potential benefits and risks for the elderly population. J. Am. Med. Assoc. 276:1879-1885.[Abstract]
53. Koehler, K. M., Pareo-Tubbeh, S. L., Liang, H. C., Romero, L. J., Baumgartner, R. N. & Garry, P. J. (1997) Some vitamin sources relating to plasma homocysteine provide not only folate but also vitamins B-12 and B-6. J. Nutr. 127:1534-1536.
54. Manore, M. M., Vaughan, L. A. & Lehman, W. R. (1990) Contribution of various food groups to dietary vitamin B-6 intake in free-living, low-income elderly persons. J. Am. Diet Assoc. 90:830-834.[Medline]
55. Selhub, J. (1999) Homocysteine metabolism. Annu. Rev. Nutr. 19:217-246.[Medline]
56. Selhub, J., Jacques, P. F., Wilson, P. W., Rush, D. & Rosenberg, I. H. (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J. Am. Med. Assoc. 270:2693-2698.[Abstract]
57. Kuller, L. H. & Evans, R. W. (1998) Homocysteine, vitamins, and cardiovascular disease. Circulation 98:196-199.
58. Friso, S., Jacques, P. F., Wilson, P. W., Rosenberg, I. H. & Selhub, J. (2001) Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation 103:2788-2791.
59. Blacher, J., Benetos, A., Kirzin, J. M., Malmejac, A., Guize, L. & Safar, M. E. (2002) Relation of plasma total homocysteine to cardiovascular mortality in a French population. Am. J. Cardiol. 90:591-595.[Medline]
60. Becker, A., Van Hinsbergh, V. W., Kostense, P. J., Jager, A., Dekker, J. M., Nijpels, G., Heine, R. J., Bouter, L. M. & Stehouwer, C. D. (2000) Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule 1, but not with C-reactive protein in type 2 diabetic and non-diabetic subjectsThe Hoorn Study. Eur. J. Clin. Investig. 30:763-770.[Medline]
61. Auer, J. W., Berent, R. & Eber, B. (2001) Lack of association of increased C-reactive protein and total plasma homocysteine [letter]. Circulation 104:E164.
This article has been cited by other articles:
![]() |
O. K. Chun, S.-J. Chung, K. J. Claycombe, and W. O. Song Serum C-Reactive Protein Concentrations Are Inversely Associated with Dietary Flavonoid Intake in U.S. Adults J. Nutr., April 1, 2008; 138(4): 753 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Houston, B. Cooil, B. J. Olafsson, and P. Raggi Juice Powder Concentrate and Systemic Blood Pressure, Progression of Coronary Artery Calcium and Antioxidant Status in Hypertensive Subjects: A Pilot Study Evid. Based Complement. Altern. Med., December 1, 2007; 4(4): 455 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L Pierce, M. A Austin, P. K Crane, B. M Retzlaff, B. Fish, C. M Hutter, D. L Leonetti, and W. Y Fujimoto Measuring dietary acculturation in Japanese Americans with the use of confirmatory factor analysis of food-frequency data Am. J. Clinical Nutrition, August 1, 2007; 86(2): 496 - 503. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gao, M. E. Nelson, and K. L. Tucker Television Viewing Is Associated With Prevalence of Metabolic Syndrome in Hispanic Elders Diabetes Care, March 1, 2007; 30(3): 694 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Esmaillzadeh, M. Kimiagar, Y. Mehrabi, L. Azadbakht, F. B Hu, and W. C Willett Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1489 - 1497. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gao, A. Martin, H. Lin, O. I. Bermudez, and K. L. Tucker {alpha}-Tocopherol Intake and Plasma Concentration of Hispanic and Non-Hispanic White Elders Is Associated with Dietary Intake Pattern J. Nutr., October 1, 2006; 136(10): 2574 - 2579. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Giugliano, A. Ceriello, and K. Esposito The Effects of Diet on Inflammation: Emphasis on the Metabolic Syndrome J. Am. Coll. Cardiol., August 15, 2006; 48(4): 677 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Nettleton, L. M Steffen, E. J Mayer-Davis, N. S Jenny, R. Jiang, D. M Herrington, and D. R Jacobs Jr Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA) Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1369 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
S G. Wannamethee, G. D. Lowe, A. Rumley, K R. Bruckdorfer, and P. H Whincup Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis Am. J. Clinical Nutrition, March 1, 2006; 83(3): 567 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Watzl, S. E Kulling, J. Moseneder, S. W Barth, and A. Bub A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men Am. J. Clinical Nutrition, November 1, 2005; 82(5): 1052 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B Schulze, K. Hoffmann, J. E Manson, W. C Willett, J. B Meigs, C. Weikert, C. Heidemann, G. A Colditz, and F. B Hu Dietary pattern, inflammation, and incidence of type 2 diabetes in women Am. J. Clinical Nutrition, September 1, 2005; 82(3): 675 - 684. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||